By Devika Patel
Knoxville, Tenn., July 20 - OncoGenex Pharmaceuticals, Inc. said it will conduct a $9.5 million registered direct offering of stock.
The company plans to sell 475,000 common shares at $20.00 per share.
Settlement is expected July 24.
Proceeds will be used primarily for manufacturing activities and general corporate purposes.
OncoGenex Pharmaceuticals, based in Bothell, Wash., is a biopharmaceutical company engaged in the development and commercialization of cancer therapies.
| Issuer: | OncoGenex Pharmaceuticals, Inc.
|
| Issue: | Common stock
|
| Amount: | $9.5 million
|
| Shares: | 475,000
|
| Price: | $20.00
|
| Warrants: | No
|
| Pricing date: | July 20
|
| Settlement date: | July 24
|
| Stock symbol: | Nasdaq: OGXI
|
| Stock price: | $20.60 at close July 20
|
| Market capitalization: | $114 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
